Skip to main content
Emily Freilich, MD, Child Neurology, Silver Spring, MD

Emily R Freilich MD


Food and Drug Administration

Join to View Full Profile
  • 10903 New Hampshire AveFood and Drug AdministrationSilver Spring, MD 20993

  • Phone+1 301-796-2044

Dr. Freilich is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Children's National Hospital/George Washington University
    Children's National Hospital/George Washington UniversityFellowship, Child Neurology, 2007
  • Children's National Hospital/George Washington University
    Children's National Hospital/George Washington UniversityResidency, Child Neurology, 2007 - 2010
  • Children's National Hospital
    Children's National HospitalResidency, Pediatrics, 2005 - 2007
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 2005

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2010 - 2026
  • CA State Medical License
    CA State Medical License 2010 - 2020
  • DC State Medical License
    DC State Medical License 2007 - 2016
  • Neurology with Special Qualification in Child Neurology
    American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Awards, Honors, & Recognition

  • Super Doctors' Rising Stars 2013
  • Northern Virginia's Top Doctors 2012-2014

Publications & Presentations

PubMed

Press Mentions

  • Children’s National Hospital to Host 35th Annual Pediatric Neurology Update
    Children’s National Hospital to Host 35th Annual Pediatric Neurology UpdateFebruary 24th, 2025
  • ALS Drug Gets FDA Panel Nod After Rare Second Review
    ALS Drug Gets FDA Panel Nod After Rare Second ReviewSeptember 8th, 2022
  • New A.L.S. Treatment Lacks Evidence of Benefit, F.D.A. Panel Finds
    New A.L.S. Treatment Lacks Evidence of Benefit, F.D.A. Panel FindsMarch 30th, 2022
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: